ar-turmerone has been researched along with beta-phellandrene in 1 studies
| Studies (ar-turmerone) | Trials (ar-turmerone) | Recent Studies (post-2010) (ar-turmerone) | Studies (beta-phellandrene) | Trials (beta-phellandrene) | Recent Studies (post-2010) (beta-phellandrene) |
|---|---|---|---|---|---|
| 41 | 0 | 29 | 54 | 0 | 38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Lateef, E; Abu Taleb, H; El-Ahwany, E; El-Sayed, M; El-Wakil, E; Hammam, O; Hassenein, H; Kandil, S; Mahmoud, F | 1 |
1 other study(ies) available for ar-turmerone and beta-phellandrene
| Article | Year |
|---|---|
Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2).
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Chromatography, Liquid; Curcuma; Curcumin; Cyclohexane Monoterpenes; Cyclohexenes; Drug Discovery; Gas Chromatography-Mass Spectrometry; Hep G2 Cells; Humans; Inhibitory Concentration 50; Ketones; Liver Neoplasms; Monoterpenes; Plant Extracts; Rhizome; Sesquiterpenes; Volatile Organic Compounds | 2016 |